НовостиBenzingaHC Wainwright & Co. Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target HC Wainwright & Co. Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target Benzinga 2026.10.27 10:39 (GMT+0) Открыть на Benzinga Другие новости